KOSDAQ - Delayed Quote KRW

Genic Co., Ltd. (123330.KQ)

Compare
25,850.00
+400.00
+(1.57%)
At close: 3:30:30 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Hyun-ho Yoo Chief Executive Officer -- -- 1970

Genic Co., Ltd.

Soulbrain Building
3rd floor 34, Pangyo-ro 255beon-gil, Bundang-gu
Seongnam-si
South Korea
82 3 1725 5600 https://www.genic21.com

Description

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

Corporate Governance

Genic Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 31, 2025 at 10:59 AM UTC - February 13, 2025 at 12:00 PM UTC

Genic Co., Ltd. Earnings Date

Recent Events